Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease

Archives of Neurology

Volumn 53, Issue 6, 1996, Pages 493-497

  Zappacosta, Boris ^a   Monza, Daniela ^a   Meoni, Cesare ^a   Austoni, Laura ^a   Soliveri, Paola ^a   Gellera, Cinzia ^a   Alberti, Roberto ^b   Mantero, Mario ^b   Penati, Gaetano ^b   Caraceni, Tommaso ^a   Girotti, Floriano ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; HALOPERIDOL; NEUROLEPTIC AGENT; TIAPRIDE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HUNTINGTON CHOREA; MALE; MENTAL CAPACITY; MENTAL DISEASE; MOTOR PERFORMANCE; NUCLEOTIDE REPEAT; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 15844429882     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1996.00550060035012     Document Type: Article

References (53)

1. Cummings JL. Behavioral and psychiatric symptoms associated with Huntington's disease. In: Weiner WJ, Lang AE, eds. Behavioral Neurology of Movement Disorders: Advances in Neurology. New York, NY: Raven Press; 1995;65:176-186.
2. Dewhurst K, Oliver J, Trick KLK, McKnight AL. Neuro-psychiatric aspects of Huntington's disease. Confina Neurol. 1969;31:258-268.
3. Folstein SE. Huntington's Disease: A Disorder of Families. Baltimore, Md: The Johns Hopkins University Press; 1989.
4. Boll TJ, Heaton R, Reitan RM. Neuropsychological and emotional correlates of Huntington's chorea. J Nerv Ment Dis. 1974;158:61-69.
5. Shiwach RS, Patel V. Aggressive behavior in Huntington's disease: a cross-sectional study in a nursing home population. Behav Neurol. 1993;6:43-47.
6. Butters N, Sax D, Montgomery K, Tarlow S. Comparison of the neuropsychological deficits associated with early and advanced Huntington's disease. Arch Neurol. 1978;35:585-589.
7. Caine ED, Shoulson I. Psychiatric syndromes in Huntington's disease. Am J Psychiatry. 1983;140:728-733.
8. Mayberg HS, Starkstein SE, Peyser CE, Brandt J, Dannals RF, Folstein SE. Paralimbic frontal lobe hypometabolism in depression associated with Huntington's disease. Neurology. 1992;42:1791-1797.
9. Morris M. Dementia and cognitive changes in Huntington's disease. In: Weiner WJ, Lang AE, eds. Behavioral Neurology of Movement Disorders: Advances in Neurology. New York, NY: Raven Press; 1995;65:187-200.
10. Lange KW, Sahakian BJ, Quinn NP, Marsden CD, Robbins TW. Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia. J Neurol Neurosurg Psychiatry. 1995;58:598-606.
11. Pillon B, Dubois B, Ploska A, Agid Y. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's and Parkinson's disease. Neurology. 1986; 36:1179-1185.
12. Andrew SE, Goldberg P, Kremer B, et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat Genet. 1993;4:398-403.
13. Ashizawa T, Wong L-JC, Richards CS, Caskey CT, Jankovic J. CAG repeat size and clinical presentation in Huntington's disease. Neurology. 1994;44:1137-1143.
14. Illarioshkin SN, Igarashi S, Onodera O, et al. Trinucleotide repeat length and rate of progression of Huntington' disease. Ann Neurol. 1994;36:630-635.
15. MacMillan JC, Snell RG, Tyler A, et al. Molecular analysis and clinical correlation's of the Huntington's disease mutation. Lancet 1993;342:954-958.
16. Snell RG, MacMillan JC, Cheadle JP, et al. Relationship between trinucleotide expansion and phenotypic variation in Huntington's disease. Nat Genet. 1993; 4:393-397.
17. Foroud T, Siemers E, Kleindorfer D, et al. Cognitive scores in carriers of Huntington's disease gene compared to non-carriers. Ann Neurol. 1995;37:657-664.
18. Bruyn GW, Went LN. Huntington's chorea. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Handbook of Clinical Neurology: Extrapyramidal Disorders. Amsterdam, the Netherlands: Elsevier Science Publishers; 1986;49:267-313.
19. Andrew SE. A CCG repeat polymorphism adjacent to the CAG repeat in the Huntington's disease gene: implications for diagnostic accuracy and predictive testing. Hum Mol Genet. 1994;3:65-67.
20. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
21. Raven JC. Guide to Using the Coloured Progressive Matrices. London, England: HK Lewis; 1965.
22. Randt CT, Brown ER, Osborne DP. A memory test for longitudinal measurement of mild to moderate deficits. Clin Neuropsychol. 1980;2:184-194.
23. Novelli G, Papagno C, Capitani E, Laiacona M, Vallar G, Cappa SF. Tre test clinici di ricerca e produzione lessicale. Taratura su soggetti normali. Arch Psicol Neurol Psichiatr. 1986;47:477-506.
24. Spinnler H, Tognoni G. Gruppo Italiano per lo Studio Neuropsicologico dell'Invecchiamento: standardizzazione e taratura Italiana di test neuropsicologici. Ital J Neurol Sci. 1987; (suppl 8).
25. Benton AL, Varney NR, Hamsher K de S. Visuospatial judgment: a clinical test. Arch Neurol. 1978;35:364-367.
26. Meazzo G, Cavarzeran F, Zappalà G, et al. The Mini-Mental State Examination normative study of an Italian random sample. Dev Neuropsychol. 1993;9(2):77-85.
27. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep. 1962; 10:799-812.
28. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32:50-55.
29. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
30. Folstein SE, Folstein MF, McHugh PR. Psychiatric syndromes in Huntington's disease. In: Chase TN, Wechsler NS, Barbeau A, eds. Huntington's Disease: Advances in Neurology. New York, NY: Raven Press; 1979;26:281-289.
31. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
32. Harper PS. Huntington's Disease. Philadelphia, Pa: WB Saunders Co; 1991.
33. Hodges JR, Salmon DP, Butters N. Differential impairment of semantic and episodic memory in Alzneimer's and Huntinglon's disease: a controlled prospective study. J Neurol Neurosurg Psychiatry. 1990;53:1089-1095.
34. Weinberger DR, Berman KF, Iadarola M, Driesen N, Zec RF. Prefrontal cortical blood flow and cognitive function in Huntington's disease. J Neurol Neurosurg Psychiatry. 1988;51:94-104.
35. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 1990;13:266-271.
36. Alexander GE, Crutcher MD, De Long MR. Basal ganglia-thalamocortical circuits: parallel subsets for motor, oculomotor, 'prefrontal' and 'limbic' functions. Prog Brain Res. 1990;85:119-146.
37. Albin RI, Young AB, Penney GB, The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989;12:366-375.
38. Stuss DT, Benson DF. Neuropsychological studies of the frontal lobes. Psychol Bull. 1984;95:3-28.
39. Burns A, Folstein S, Brandt J, Folstein M. Clinical assessment of irritability, aggression, and apathy in Huntington's and Alzheimer's disease. J Nerv Ment Dis. 1990;178:20-26.
40. Cummings JL. Frontal-subcortical circuits and human behavior. Arch Neurol. 1993;50:873-880.
41. Richfield EK, Herkenham M. Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus. Ann Neurol. 1994;36:577-584.
42. Richfield EK, Maguire-Zeiss KA, Cox C, Gilmore J, Voorn P. Reduced expression of preproenkephalin in striatal neurones from Huntington's disease patients. Ann Neurol. 1995;37:335-343.
43. Starkstein SE, Bolduc PL, Mayberg HS, Preziosi TJ, Robinson RG. Cognitive impairment and depression in Parkinson's disease: a follow-up study. J Neurol Neurosurg Psychiatry. 1990;53:597-602.
44. Starkstein SE, Mayberg HS, Leiguarda R, Preziosi TJ, Robinson RG. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 1992;55:377-382.
45. Troster AI, Paolo AM, Lyons KE, Glatt SI, Hubble JP, Koller WC. The influence of depression on cognition in Parkinson's disease: a pattern of impairment distinguishable from Alzheimer's disease. Neurology. 1995;45:672-676.
46. Bathia KP, Marsden CD. The behavioral and motor consequences of focal lesions of the basal ganglia in man. Brain. 1994;117:859-876.
47. Mendez MF, Adams NL, Lewandowski KS. Neurobehavioural changes associated with caudate lesions. Neurology. 1989;39:349-354.
48. Oliva D, Carella F, Savoiardo M, et al. Clinical and magnetic resonance features of the classic and akinetic-rigid variant's of Huntington's disease. Arch Neurol. 1993;50:17-20.
49. Read AP. Huntington's disease: testing the test. Nat Genet. 1993;4:329-330.
50. Claes S, Van Zand K, Legius E, et al. Correlations between triplet repeat expansion and clinical features in Huntington's disease. Arch Neurol. 1995;113:749-753.
51. Telenius H, Kremer B, Godberg YP, et al. Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nat Genet. 1994; 6:409-414.
52. Landwehrmeyer GB, McNeil SM, Dure LS, et al. Huntington's disease gene: regional and cellular expression in brain of normal and affected individuals. Ann Neurol. 1995;37:218-230.
53. Starkstein SE, Vazquez S, Migliorelli R, Teson A, Sabe L, Leiguarda R. A single photon emission computed tomographic study of anosognosia in Alzheimer's disease. Arch Neurol. 1995;52:415-420.